SE8203692L - Saliva stimulating tablet contg. weak organic acid - also contains calcium phosphate and surfactant to inhibit corrosive effect on teeth - Google Patents
Saliva stimulating tablet contg. weak organic acid - also contains calcium phosphate and surfactant to inhibit corrosive effect on teethInfo
- Publication number
- SE8203692L SE8203692L SE8203692A SE8203692A SE8203692L SE 8203692 L SE8203692 L SE 8203692L SE 8203692 A SE8203692 A SE 8203692A SE 8203692 A SE8203692 A SE 8203692A SE 8203692 L SE8203692 L SE 8203692L
- Authority
- SE
- Sweden
- Prior art keywords
- tablet
- calcium phosphate
- organic acid
- weak organic
- contg
- Prior art date
Links
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 title abstract 4
- 239000001506 calcium phosphate Substances 0.000 title abstract 3
- 229910000389 calcium phosphate Inorganic materials 0.000 title abstract 3
- 235000011010 calcium phosphates Nutrition 0.000 title abstract 3
- 150000007524 organic acids Chemical class 0.000 title abstract 2
- 210000003296 saliva Anatomy 0.000 title abstract 2
- 230000000471 effect on teeth Effects 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 title 1
- 239000004094 surface-active agent Substances 0.000 title 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 abstract 1
- 235000019731 tricalcium phosphate Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
Tablet for long term use contains calcium phosphate for preventing release of tooth's own calcium phosphate. A surface active component gives the surface of the tooth a hydrophobic character. A low level of weak organic acid is also present. The tablet can contain, e.g. approx 88% sorbitol, 4% malic aicd, 2% citric acid, 4% sodium citrate, 2% Ca3(PO4)2 and 1% surface active component, e.g. magnesium stearate. The compsn. is balanced so that when the tablet is in 4 ml of saliva, its pH does not exceed 4. Each tablet weights at least 400 mg. (Provisional Basic previously advised in Week 8406).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8203692A SE8203692L (en) | 1982-06-15 | 1982-06-15 | Saliva stimulating tablet contg. weak organic acid - also contains calcium phosphate and surfactant to inhibit corrosive effect on teeth |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8203692A SE8203692L (en) | 1982-06-15 | 1982-06-15 | Saliva stimulating tablet contg. weak organic acid - also contains calcium phosphate and surfactant to inhibit corrosive effect on teeth |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE8203692L true SE8203692L (en) | 1983-12-16 |
Family
ID=20347062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8203692A SE8203692L (en) | 1982-06-15 | 1982-06-15 | Saliva stimulating tablet contg. weak organic acid - also contains calcium phosphate and surfactant to inhibit corrosive effect on teeth |
Country Status (1)
| Country | Link |
|---|---|
| SE (1) | SE8203692L (en) |
-
1982
- 1982-06-15 SE SE8203692A patent/SE8203692L/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTIP1472A (en) | Composition of priming hard tissue of tooth | |
| PH21135A (en) | Oral hygiene composition | |
| EP0179396A3 (en) | Mouth and tooth care compositions | |
| JPS6438020A (en) | Therapy | |
| MX9603278A (en) | Novel complex salts of phosphoric and amino acids and ruminant feed additive composition containing the same. | |
| ES8700054A1 (en) | Improved germicide composition. | |
| SE8203692L (en) | Saliva stimulating tablet contg. weak organic acid - also contains calcium phosphate and surfactant to inhibit corrosive effect on teeth | |
| IL103799A (en) | Fish production | |
| AU570446B2 (en) | Dipyridamole controlled release compositon | |
| SE8701077D0 (en) | PHARMACEUTICAL COMPOSITION | |
| ES2013342A6 (en) | Pharmaceutical composition for preventing and treating bacterial or viral diseases. | |
| EP0137436A3 (en) | Oral hygiene compositon | |
| JPS57118509A (en) | Novel preparation of high absorbability | |
| EP0192327A3 (en) | Use of phosphonoformic acid and its esters and salts for the manufacture of a medicament for the treatment of AIDS | |
| EP0290186A3 (en) | Use of oral compositions comprising anti-calculus agents | |
| JPS57146708A (en) | Novel oral preparation | |
| DE3474039D1 (en) | Mixtures containing nitrilotriacetic acid and iminodiacetic acid (or salts thereof) as a sequestering agent | |
| MY108055A (en) | Dental tray. | |
| IT1214424B (en) | Anti-tartar chewing gum | |
| IT1211746B (en) | Anti-tartar chewing gum | |
| SE8404315L (en) | WATER PREPARATION PREPARATION FOR AQUACULTURE AND PROCEDURE FOR WATER PREPARATION | |
| JPS57118513A (en) | Cardiac function improver |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8203692-2 Effective date: 19880610 |